Patient Engagement and Recruitment
Leveraging Data, Technology, and Community Engagement
14/10/2025 - 15 October 2025 ALL TIMES CET (UTC +2h)
Patient recruitment remains one of the most significant challenges in clinical research, leading to costly delays and, more importantly, slowing the delivery of new therapies to patients in need. As sponsors, clinical researchers, study teams, and innovation leaders navigate the evolving landscape of hybrid and decentralised trials, they are also striving to better identify, understand, and engage diverse patient populations. The Patient Engagement and Recruitment conference explores strategies to enroll for global trials, leverage data analytics to improve recruitment, pathways to engage diverse populations, and how to leverage technology without losing sight of potential technology burden.

Monday, 13 October

Registration Open

MONDAY AFTERNOON WORKSHOPS & USER GROUP (IN-PERSON ONLY)

– 15:15 WORKSHOP 1: Nuts and Bolts of AI Implementation: What to Avoid and What to Emphasise (Sponsorship Opportunity Available)

INSTRUCTORS:
Jonathan Crowther, PhD, Head, Operational Design Center, Merck KGaA, Darmstadt, Germany
Prasanna Rao, Chief Products and Innovation Officer, Saama
This interactive workshop will provide a practical overview of key considerations for implementing AI in clinical operations and beyond. Topics will include ethical implications and regulatory updates such as the EU AI Act, a clear explanation of AI APIs and how they function, and best practices for effective prompt engineering. Attendees will gain valuable insights into common pitfalls to avoid and strategies to successfully integrate AI tools in a regulated environment.

– 17:00 USER GROUP: Citeline Industry Roundtable (Invitation Only)

– 17:00 WORKSHOP 2: Modernising Informed Consent: AI, Automation, and Ethics in Global Clinical Trials

INSTRUCTORS:

Pooja Bholanath Pagare, Manager, Clinical Development, ZS Associates

Kirstin Goldring, Senior Director/Head, HBS Compliance and Governance, AstraZeneca

Sofiane Nacia, Director, Senior Global Process Owner, Novartis

Hilde Vanaken, Head EFGCP eConsent Initiative, EFGCP – European Forum for Good Clinical Practice

Brenda Yanak, Former Vice President, Bristol Myers Squibb Co.; Founder, Clinical Transformation Partners LLC​

As clinical trials grow in complexity and scale, the role of informed consent becomes more critical—and more challenging—than ever. This interactive workshop explores the evolving landscape of consent in the digital age, from the automation of consent form development to navigating global ethics and privacy regulations. We'll examine the responsibilities embedded in consent language, new international policies designed to uphold participant rights, and the use of AI-powered tools to review, manage, and search consent documents for transparency and compliance. Designed for the broader clinical operations community, this session will be especially valuable for professionals focused on consent processes, patient recruitment, study start-up, site activation, decentralised trials, clinical technology, and clinical data. Attendees will leave with actionable insights into how technology can safeguard ethics while streamlining consent workflows across diverse trial environments.

– 18:45 WORKSHOP 3: Tackling Kit Wastage for Greener Clinical Trials (Sponsorship Opportunity Available)

INSTRUCTORS:

Michael J. Cohen, MSc, MBA, SEP, Senior Director, Lead, Environmental Sustainability, Thermo Fisher Scientific
Thierry Escudier, Portfolio Lead, Pistoia Alliance
Celine Gervais, CEO, Quipment SAS 
Peter Morley, Clinical Sustainability Manager, Process Transformation & Digitalization, Novo Nordisk A/S
Diana Steinbuesch, Founding Member, Biospecimen Management Consortium (BMC); BioX Operations Portfolio Lead (Oncology), Roche

ESG (Environmental, Social, & Governance) Leaders in Pharma & Sustainable Trials Workshop at SCOPE. Join us for an insightful workshop on optimising clinical trial supply management. Discover strategies to minimise supply overage and kit wastage, while enhancing environmental sustainability. Learn from industry experts how to implement best practices that reduce waste, lower costs, and reduce greenhouse gas emissions in clinical trials. This workshop is essential for professionals committed to improving efficiency and sustainability in clinical research.​

Tuesday, 14 October

MORNING COFFEE AND CONFERENCE SESSIONS

SCOPE Europe Fun Run

RUN COORDINATORS: 

Bridget Kotelly, Senior Conference Director, Cambridge Healthtech Institute
Eileen Murphy, Conference Producer, Production, Cambridge Healthtech Institute
Join SCOPE’s Coordinators on Tuesday morning for our Rise and Shine Fun Run! Don’t forget to pack your sneakers. All of us at Cambridge Healthtech Institute recognizse the importance of integrating well-being and fitness into our work travel routines. We're excited to offer our support to faculty, sponsors, and attendees in fostering a culture of wellness. This is an easygoing, informal running (or walking) event. No time chips, running bibs, or energy bars—just a laid-back opportunity for a small group to start the day on a positive note. You can sprint, run, jog, walk, jog-and-talk, or walk-and-talk—the goal is to get up and get moving! Meet us in the front lobby near the concierge at 6:45 am sharp! 

Registration and Morning Coffee

Organiser's Welcome Remarks

MODERNISING RECRUITMENT & ENGAGEMENT

Mining EHRs for Smarter, Faster Recruitment in Clinical Trials

Photo of Nadir Ammour, DDS, MBA, Global Lead Engagement & Strategic Collaborations, Sanofi R&D Clinical Operations , Engagement & Strategic Collaboration - Global Lead , Engagement & Strategic Collaborations , Sanofi R&D
Nadir Ammour, DDS, MBA, Global Lead Engagement & Strategic Collaborations, Sanofi R&D Clinical Operations , Engagement & Strategic Collaboration - Global Lead , Engagement & Strategic Collaborations , Sanofi R&D

Clinical trial recruitment remains a significant challenge in drug development, particularly as advances in medical innovation and research introduce more complex eligibility criteria. Despite the widespread digitisation of healthcare, with over 90% of patient records now electronic, leveraging Electronic Health Records (EHRs) for data-driven decision-making in site selection and patient recruitment has seen limited progress. This presentation will explore Sanofi's initiatives in enhancing recruitment and patient matching methodologies through the use of EHR data. We will discuss early results, share lessons learned, and provide recommendations for broader adoption of these data-driven approaches.

Clinical Trial Experience Surveys as a Tool to Increase Patient, Caregiver, and Site Staff Satisfaction: Results from a Sponsor-Wide Implementation across Countries and Therapy Areas

Photo of Kimberley Kallsen, Head of Patient & Site Engagement, Global Clinical Development & Operations, Boehringer Ingelheim , Head of Patient & Site Engagement, Global Clinical Development Operations , Global Clinical Development Operations , Boehringer Ingelheim Pharma GmbH & Co KG
Kimberley Kallsen, Head of Patient & Site Engagement, Global Clinical Development & Operations, Boehringer Ingelheim , Head of Patient & Site Engagement, Global Clinical Development Operations , Global Clinical Development Operations , Boehringer Ingelheim Pharma GmbH & Co KG

Clinical trial experience survey templates were co-created with patients and site staff and implemented in all trials; across countries and therapy areas. Results can be tracked in real-time via a dashboard, with the opportunity to look at trial-, country-, and site-level. The first analysis is based on the first +3000 responses and identifies concrete actions to enhance patient and site staff satisfaction with clinical trials.

High-Realistic Simulation in Clinical Trials

Photo of Begonya Nafria Escalera, Patient Engagement & Research Coordinator, eYPAGnet, Sant Joan de Deu Barcelona Hospital , Patient Engagement & Research Coordinator , Patients Engagement in Research , Sant Joan de Deu Barcelona Hospital
Begonya Nafria Escalera, Patient Engagement & Research Coordinator, eYPAGnet, Sant Joan de Deu Barcelona Hospital , Patient Engagement & Research Coordinator , Patients Engagement in Research , Sant Joan de Deu Barcelona Hospital

High-fidelity simulation enables the replication of clinical trial activities that may present challenges, within a secure environment, prior to the finalization of the study protocol or the initiation of the trial. This method of testing and piloting clinical research procedures can offer significant benefits for logistics and operations, and especially for the experience of patients and families as future participants in the clinical study.

Grand Opening Coffee Break in the Exhibit Hall

The SCOPE Europe Exhibit Hall is the best place to fuel up with a mid-morning coffee while visiting with our many exhibitors. Learn about what’s new in the industry, connect with colleagues and partners, and make some new friends.

TUESDAY MORNING PLENARY SESSION: ACCELERATING THE FUTURE OF CLINICAL TRIALS: AI, EXECUTION, AND COLLABORATIVE DESIGN

Grab Your Seat: Plenary Keynote Seat Raffle & Prize Giveaway!* 

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute; Co-Founder, ClinEco , Executive Director , Cambridge Healthtech Institute

*Must be present to win!

Welcome to SCOPE Europe—Who Is Here and Why?

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute; Co-Founder, ClinEco , Executive Director , Cambridge Healthtech Institute

KEYNOTE PRESENTATION:
Transformative AI: Shaping the Future of Healthcare

James Weatherall, PhD, Vice President & Chief Data Scientist, BioPharmaceuticals R&D, AstraZeneca , VP & Chief Data Scientist , BioPharmaceuticals R&D , AstraZeneca

Artificial intelligence is transforming medicines development, paving the way for enhanced patient outcomes and organisational success. By deriving actionable insights from complex datasets, we are accelerating the discovery of novel targets, elucidating intricate disease mechanisms, and improving how we approach clinical trials. The vast and exciting future applications of AI will deliver the next frontier in healthcare, urging us to reimagine innovation and advance science, with the goal of bringing new, better medicines to patients, faster.

Meet Your Neighbor: What Is YOUR Biggest Technological or Operational Challenge Right Now?

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute; Co-Founder, ClinEco , Executive Director , Cambridge Healthtech Institute

KEYNOTE CASE STUDY CO-PRESENTATION:
Learning from Lightspeed Execution of the OCEANIC STROKE Program

Alexander Krupp, PhD, Vice President, Executive Clinical Program Excellence Lead, Bayer AG , VPq , Executive Clinical Program Excellence Lead , Bayer AG

Georgios Tsivgoulis, MD, PhD, Professor of Neurology, National & Kapodistrian University Of Athens; President, Hellenic Neurological Society , Professor of Neurology , University of Athens

More than 14 million patients experience a stroke every year. Preventing as many stroke events as possible will retain a high quality of life for patients, their caregivers, and society—and is therefore of high relevance. For Bayer’s OCEANIC program in stroke, we have established a product-centric operational model that has resulted in the competitor feedback: “You are killing us with excellence—how are you doing this?” In this keynote, we will explore how our industry can learn from high performance operating models to serve our patients faster, better, and at lower cost.

Panel Moderator:

KEYNOTE PANEL DISCUSSION:
Closing the Gap between Protocol Development and Feasibility to Ensure Downstream Success with Sites and Patients

Ken Getz, Executive Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine , Executive Director and Professor, Tufts Center for the Study of Drug Development. , Tufts University School of Medicine

Panelists:

Bernhard Glombitza, Head, Clinical Operations EMEA and LATAM, Bayer , Head Clinical Customer Engagement and Clinical Operations EMEA/LATAM , Clinical Development & Operations , Bayer

Christian Milliet, Head of Site & Healthcare Ambassadors, Clinical Development Operations, CSL Behring , Head of Site & Healthcare Ambassadors , Clinical Development Operations , CSL Behring

Susana Ramos, PhD, Global Early Planning TA Lead, Clinical Sciences & Operations, Sanofi , Global Early Planning TA Lead , Clinical Sciences & Operations , Sanofi Grp

Matthieu Ruffin, Head Study Leadership, SSO GCO Development, Novartis , Head Study Leadership , SSO GCO Development , Novartis

Join Your Peers for a Networking Luncheon in the Exhibit Hall

Take this opportunity to refresh and refuel with our Exhibit Hall lunch. Enjoy good food and even better conversation during our walk and talk luncheon.

PATIENT-CENTERED APPROACHES TO ENGAGEMENT & RETENTION

Chairperson's Remarks

Amy Froment, Head of Study Start-Up & Feasibility, Jazz Pharmaceuticals , Head of Feasibility and Study Start-Up , Global Clinical Development Operations , Jazz Pharmaceuticals

Aligning Patient Engagement with Corporate Branding: Best Practices and Innovations

Photo of Olivier Flexas, Digital Product Line Owner, Patient Experience & Data Capture, Sanofi , Digital Product Line Owner , Patient Experience & Data Capture , sanofi
Olivier Flexas, Digital Product Line Owner, Patient Experience & Data Capture, Sanofi , Digital Product Line Owner , Patient Experience & Data Capture , sanofi
Photo of Sarah McClure, Global Data Engagement Lead, Feasibility Management, R&D, Sanofi , Global Data Engagement Lead – Feasibility Management , R&D , Sanofi
Sarah McClure, Global Data Engagement Lead, Feasibility Management, R&D, Sanofi , Global Data Engagement Lead – Feasibility Management , R&D , Sanofi

This discussion addresses the fragmented landscape of clinical trial recruitment, where siloed digital outreach diminishes participant experience. We demonstrate how unified branding creates a seamless patient journey, enabling individuals researching health conditions to naturally discover relevant clinical trials. This integration transforms disconnected touchpoints into a cohesive ecosystem, enhancing trust and recognition while providing value through contextually-relevant trial opportunities that align with patients' existing health information–seeking behaviours.

Patient and HCP Inspired Solutions that Improve the Participant and Site Experience—Case Study

Photo of Annie Gilbert, Lead, Global Patient & Site Engagement, Boehringer Ingelheim Ltd. , Global Patient and Site Engagement Lead , Global Patient & Site Engagement , Boehringer Ingelheim Ltd
Annie Gilbert, Lead, Global Patient & Site Engagement, Boehringer Ingelheim Ltd. , Global Patient and Site Engagement Lead , Global Patient & Site Engagement , Boehringer Ingelheim Ltd

The presentation will explore innovative strategies that improved the patient and site experience in a Phase 3 trial. Central to this approach was a trial simulation, and critical to the success of it was the involvement of patient and site advisors, whose input was instrumental in adjusting the trial protocol and conduct. These adjustments led to significant outcomes, including fast recruitment, retention figures meeting targets, and excellent trial experience survey results.

READI, the Public-Private Partnership to Increase Inclusiveness in Clinical Studies in Europe

Photo of Maria Dutarte, Executive Director, European Patients’ Academy on Therapeutic Innovation (EUPATI); Project Partner and Workpackage Co-Lead, READI Project Consortium , Executive Director , European Patients’ Academy on Therapeutic Innovation (EUPATI)
Maria Dutarte, Executive Director, European Patients’ Academy on Therapeutic Innovation (EUPATI); Project Partner and Workpackage Co-Lead, READI Project Consortium , Executive Director , European Patients’ Academy on Therapeutic Innovation (EUPATI)

Paloma Moraga, Researcher at Fundación para la investigación biomédica del Hospital Universitario La Paz (IdiPAZ/SERMAS) - Coordinator of the READI Project Consortium

Photo of José Luis Narro, European Projects Coordinator, Fundación para la investigación biomédica del Hospital Universitario La Paz  (IdiPAZ) -  Coordinator of the READI Project Consortium , HEAD OF INTERNATIONAL PROJECTS , LA PAZ UNIVERSITY HOSPITAL
José Luis Narro, European Projects Coordinator, Fundación para la investigación biomédica del Hospital Universitario La Paz (IdiPAZ) - Coordinator of the READI Project Consortium , HEAD OF INTERNATIONAL PROJECTS , LA PAZ UNIVERSITY HOSPITAL
Photo of Robina Weermeijer, Patient & Site Engagement Lead, Boehringer Ingelheim , Boehringer Ingelheim
Robina Weermeijer, Patient & Site Engagement Lead, Boehringer Ingelheim , Boehringer Ingelheim

The READI project consortium https://ihi-readi.org/ is a large public-private 6-year undertaking jointly financed by the EU and industry, focusing on inclusiveness in clinical studies. This initiative brings together over 70 partners from Europe (and worldwide, also 8 patient organisations) to understand and overcome challenges in this area.

Reception in the Exhibit Hall with Beer, Wine, and Tapas

Wind down at the end of a busy session day with colleagues, beer, wine, and tapas. Have a drink with your favorite exhibitor and take a chance at winning a fabulous raffle prize (must be present to win)!

Close of Day

Wednesday, 15 October

Registration and Morning Coffee

ADVANCING EQUITY AND REPRESENTATION IN CLINICAL RESEARCH

Chairperson's Remarks

Robina Weermeijer, Patient & Site Engagement Lead, Boehringer Ingelheim , Boehringer Ingelheim

Representation in Global Lung Cancer Trials

Photo of Emily Avent, Senior Account Director, Langland , Senior Account Director , Clinical Trial Experience , Langland
Emily Avent, Senior Account Director, Langland , Senior Account Director , Clinical Trial Experience , Langland
Photo of Gracia Hyatt , Clinical Trial Manager , Boehringer Ingelheim
Gracia Hyatt , Clinical Trial Manager , Boehringer Ingelheim
Photo of Robina Weermeijer, Patient & Site Engagement Lead, Boehringer Ingelheim , Boehringer Ingelheim
Robina Weermeijer, Patient & Site Engagement Lead, Boehringer Ingelheim , Boehringer Ingelheim

Designing global clinical trials that reflect all patient needs is complex due to varying healthcare systems and experiences. This presentation highlights a collaboration between global and country-based teams, focusing on demographic insights across countries and a deep dive into lived experiences of Black and South Asian communities in the UK to inform more inclusive trial design.

Patient Engagement Approaches in Research and Development

Photo of Laura Risueño Ayerbe, R&D Patient Officer – Global Patient Affairs, Servier , Global Patient Affairs, Patient Engagement R&D , SERVIER
Laura Risueño Ayerbe, R&D Patient Officer – Global Patient Affairs, Servier , Global Patient Affairs, Patient Engagement R&D , SERVIER

Patient-centered strategies are increasingly recognized as essential in shaping successful research and development programs. This presentation will explore how integrating patient perspectives throughout the drug development process can enhance clinical trial design, inform medical communications, and optimize treatment outcomes. Drawing on real-world examples and practical initiatives, we will discuss approaches for meaningful patient engagement, collaboration across multidisciplinary teams, and strategies for translating patient insights into actionable outcomes. 

Coffee Break in the Exhibit Hall

More coffee, more exhibitors, more networking, and some delicious snacks. What’s not to love?

WEDNESDAY MORNING PLENARY SESSION: SCALING SMARTER TRIALS: NETWORKS, AI, AND THE NEW CLINICAL RESEARCH INFRASTRUCTURE

Networking Game, SCOPE Quiz & Prize Giveaway!

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute; Co-Founder, ClinEco , Executive Director , Cambridge Healthtech Institute

Chairperson's Remarks

Panel Moderator:

KEYNOTE PANEL DISCUSSION:
Embracing the Power of Networks to Expand Pharma's Research Footprint and Improve Recruitment

Terttu Haring, MD, Global Head, Engagement Strategy (Sites & Patients), Johnson & Johnson Innovative Medicine , Global Head, Engagement Strategy (Sites & Patients) , Johnson & Johnson Innovative Medicine

Panelists:

Javier Carmona, PhD, Head of Scientific Strategy & Translational Programs, Vall d’Hebron Institute of Oncology (VHIO); CSO, Cancer Core Europe , Head of Scientific Strategy, Chief Scientific Officer , Vall d’Hebron Institute of Oncology (VHIO), Cancer Core Europe (CCE)

Astrid Schut, Managing Director, WCN (Werkgroep Cardiologische centra Nederland) , Managing Director , WCN (Werkgroep Cardiologische centra Nederland)

Panel Moderator:

KEYNOTE PANEL DISCUSSION:
AI in Clinical Trials: Where Science Meets Systems—Bridging Operational Expertise with Technical Innovation

Allison Proffitt, Editorial Director, Bio-IT World and Clinical Research News , Editorial Dir , Bio-IT World

Panelists:

Jonathan Crowther, PhD, Head, Operational Design Center, Merck KGaA, Darmstadt, Germany , Head, Operational Design Center , Merck KGaA, Darmstadt, Germany

Janie Hansen, Business Systems Transformation, Global Development Information Management, Daiichi Sankyo, Inc. , Business Systems Transformation , Global Development Information Management , Daiichi Sankyo Inc

Francis Kendall, Head of Statistical Programming, Digital and Data Sciences, Biogen , Head of Statistical Programming, Digital and Data Sciences , Biogen

James Weatherall, PhD, Vice President & Chief Data Scientist, BioPharmaceuticals R&D, AstraZeneca , VP & Chief Data Scientist , BioPharmaceuticals R&D , AstraZeneca

Join your Peers for a Networking Luncheon in the Exhibit Hall

Join us again for lunch in the Exhibit Hall. Last chance to visit with exhibitors you missed and to enter our final raffle!

ELEVATING PARTICIPANT EXPERIENCE

Bridging the Gap—Shaping the Future of Individual Data Return in Clinical Trials

Photo of Ivet Aldabo, Customer Strategy Lead, Bayer , Global Clinical Customer Strategy Lead , CD&O - CDPE - Clinical Customer Centricity , Bayer
Ivet Aldabo, Customer Strategy Lead, Bayer , Global Clinical Customer Strategy Lead , CD&O - CDPE - Clinical Customer Centricity , Bayer
Photo of Josephine Scrofani, Customer Strategy Lead, Bayer , Customer Strategy Lead , Clinical Development & Operations, Clinical Customer Centricity , Bayer Pharmaceuticals
Josephine Scrofani, Customer Strategy Lead, Bayer , Customer Strategy Lead , Clinical Development & Operations, Clinical Customer Centricity , Bayer Pharmaceuticals

Join us for an insightful session on the benefits and challenges of returning individual data to clinical trial participants. Discover how a patient-centric approach empowers individuals to own their health information. We’ll discuss identifying valuable data, presenting it in user-friendly formats, ensuring regulatory compliance, assessing infrastructure needs, and engaging with patient advocacy groups. Don’t miss this opportunity to enhance participant experiences and improve the overall impact of clinical trials.

Panel Moderator:

PANEL DISCUSSION:
From Insight to Impact: Reframing Clinical Development through Patient Preference

Photo of Emma Sutcliffe, Chief Patient Officer, ISPEP , Global Patient Officer , Patient Affairs , ISPEP
Emma Sutcliffe, Chief Patient Officer, ISPEP , Global Patient Officer , Patient Affairs , ISPEP

Panelists:

Photo of Steve Clark, Patient Advocate, Strive for Five and Beyond , Patient Advocate and Patient Engagement Consultant , StriveForFive.org
Steve Clark, Patient Advocate, Strive for Five and Beyond , Patient Advocate and Patient Engagement Consultant , StriveForFive.org
Photo of Stacey Davidson, Head of Content & Strategy, Cuttsy & Cuttsy , Head of Content and Strategy , Cuttsy + Cuttsy
Stacey Davidson, Head of Content & Strategy, Cuttsy & Cuttsy , Head of Content and Strategy , Cuttsy + Cuttsy
Photo of Peter DiBiaso MHSA, Patient Advocate, Life Sciences Principal Consultant , Principal , Life Sciences , Development Advisory Partners
Peter DiBiaso MHSA, Patient Advocate, Life Sciences Principal Consultant , Principal , Life Sciences , Development Advisory Partners
Photo of Melissa Harris, Global Head, Patient Recruitment & Engagement, Fortrea , Global Head , Patient Recruitment & Engagement , Fortrea
Melissa Harris, Global Head, Patient Recruitment & Engagement, Fortrea , Global Head , Patient Recruitment & Engagement , Fortrea

Session Break

WEDNESDAY AFTERNOON PLENARY SESSION: THE FUTURE WE BUILD: RECOGNISING INNOVATION, RESTORING EUROPE’S ROLE, AND RECLAIMING THE PATIENT VOICE

Grab Your Seat: Plenary Keynote Seat Raffle & Prize Giveaway! (Sponsorship Opportunity Available)

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute; Co-Founder, ClinEco , Executive Director , Cambridge Healthtech Institute

CLINICAL RESEARCH NEWS' BEST-OF-SHOW AWARD:
Recognising Exceptional Innovation in Technologies Used by Clinical Research Professionals

Allison Proffitt, Editorial Director, Bio-IT World and Clinical Research News , Editorial Dir , Bio-IT World

Sponsored by Clinical Research News & ClinEco
The 2025 Best-of-Show Awards offer exhibitors of the SCOPE Summit Europe an exclusive opportunity to distinguish and highlight their products, including innovative applications, technologies, tools, and solutions. The SCOPE community is invited to identify exceptional innovation in technologies used by life-science professionals, voting on the most impactful new products of the year. Submit your entry! https://www.scopesummiteurope.com/sponsor-exhibitor/best-of-show-awards

KEYNOTE FIRESIDE CHAT:
Trials Are Leaving Europe—Can We Bring Them Back?

Moe Alsumidaie, Chief Editor, Editorials, Clinical Trial Vanguard , Chief Editor , Editorials , Clinical Trial Vanguard

Adama Ibrahim, Vice President, Digital Strategy & Change Management, Novo Nordisk , VP Digital Strategy and Change Management , Digital Science & Innovation , Novo Nordisk

Tero Laulajainen, Vice President, Head of Global Clinical Operations, UCB , VP - Global Clinical Science and Operations , Head of Global Clinical Operations , UCB

This keynote panel will address the decline in clinical trial activity across the European Union and what it will take to reverse the trend. Topics will include ethics review fragmentation, trial startup delays, cost pressures, site performance, and underrepresentation of EU citizens in global clinical trial data. The panel will explore how regulatory guidance, public-private collaboration, and ACT EU can collectively restore Europe's competitiveness in clinical development.

KEYNOTE FIRESIDE CHAT:
Patient Engagement to Shape Trial Design and Operations around Unmet Patients’ Needs

Alfonso Aguarón, Patient Advocate; Patient Engagement Director, Patvocates , Patient Engagement Director , Patvocates

Gonzalo Linares, Senior Director & Global Head, Patient Advocacy & External Engagement R&D, Johnson & Johnson AG , Senior Director, Global Head Patient Advocacy R&D , Patient Advocacy & External Engagement R&D , Johnson & Johnson AG

This dynamic session brings together the voices of industry and patients to explore how meaningful patient engagement can transform clinical trial design and execution. A pharma leader and a patient advocate will share real-world examples of collaboration that led to more inclusive protocols, improved recruitment, and enhanced trial experiences. Attendees will gain practical insights into embedding patient perspectives early and often to address unmet needs and drive better outcomes. Join us to learn how co-creating with patients is not just the right thing to do—it’s a strategic imperative.

Closing Remarks and Next Steps

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute; Co-Founder, ClinEco , Executive Director , Cambridge Healthtech Institute

Close of Conference


For more details on the conference, please contact:

Bridget Kotelly

Senior Conference Director

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781-972-5404

Email: bkotelly@cambridgeinnovationinstitute.com

 

For sponsorship information, please contact:

 

Companies A-E:

Ilana Quigley

Director, Sales

Cambridge Healthtech Institute

Phone: (+1) 781-972-5457

Email: iquigley@healthtech.com

 

Companies F-N:

Katelin Fitzgerald

Senior Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-247-1824

Email: kfitzgerald@cambridgeinnovationinstitute.com

 

Companies O-V:

Jon Stroup

Lead Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5483

Email: jons@healthtech.com

 

Companies W-Z:

Patty Rose

Vice President, Sales

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781-972-1349

Email: prose@healthtech.com

 

For media and association partnerships, please contact:

Rich Handy

Associate Vice President, Marketing

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781-972-5456

Email: rhandy@healthtech.com